Mass screening for neuroblastoma at 6 months of age: Difficult to justify
- 1 November 1998
- journal article
- research article
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 33 (11) , 1674-1678
- https://doi.org/10.1016/s0022-3468(98)90607-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Neuroblastoma screening in infants postponed after the sixth month of age: A trial to reduce “overdiagnosis” and to detect cases with “unfavorable” biologic featuresMedical and Pediatric Oncology, 1997
- Mass screening for neuroblastoma and mortality in birth cohortsInternational Journal of Cancer, 1997
- Natural history of neuroblastoma found by mass screeningThe Lancet, 1997
- A population-based study of the usefulness of screening for neuroblastomaThe Lancet, 1996
- Mass screening for neuroblastoma: Quo vadis? A 9-year experience from the pediatric oncology study group of the Kyushu area in JapanJournal of Pediatric Surgery, 1996
- Problems of neuroblastoma screening for 6 month olds and results of second screening for 18 month oldsJournal of Pediatric Surgery, 1995
- How to deal with advanced cases of neuroblastoma detected by mass screening: A report from the pediatric oncology study group of the Kyushu area of JapanJournal of Pediatric Surgery, 1994
- Neuroblastomscreening-Projekt ,,Niedersachsen/Nordrhein-Westfalen": Zur Notwendigkeit des epidemiologischen VergleichsKlinische Padiatrie, 1992
- Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older childrenThe Journal of Pediatrics, 1991
- Neuroblastoma. Mass screening for early detection and its prognosisCancer, 1984